{"nct_id":"NCT00777309","title":"A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)","status":"COMPLETED","status_verified_date":"2013-02","start_date":"2008-09","start_date_type":null,"primary_completion_date":"2011-05","primary_completion_date_type":"ACTUAL","completion_date":"2011-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}